Sequoia Financial Advisors LLC raised its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 67.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,898 shares of the biotechnology company's stock after buying an additional 1,171 shares during the quarter. Sequoia Financial Advisors LLC's holdings in Axon Enterprise were worth $1,722,000 at the end of the most recent reporting period.
Several other institutional investors also recently modified their holdings of the stock. Prestige Wealth Management Group LLC lifted its stake in Axon Enterprise by 115.8% in the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company's stock valued at $33,000 after acquiring an additional 44 shares in the last quarter. New Wave Wealth Advisors LLC bought a new stake in Axon Enterprise in the 4th quarter valued at approximately $40,000. Brooklyn Investment Group bought a new stake in Axon Enterprise in the 3rd quarter valued at approximately $41,000. Y.D. More Investments Ltd bought a new stake in Axon Enterprise in the 4th quarter valued at approximately $45,000. Finally, Planning Capital Management Corp lifted its stake in Axon Enterprise by 83.3% in the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company's stock valued at $48,000 after acquiring an additional 55 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling
In other Axon Enterprise news, insider Jeffrey C. Kunins sold 1,035 shares of Axon Enterprise stock in a transaction dated Monday, December 23rd. The shares were sold at an average price of $624.47, for a total value of $646,326.45. Following the completion of the sale, the insider now owns 124,243 shares in the company, valued at $77,586,026.21. The trade was a 0.83 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Jeri Williams sold 307 shares of Axon Enterprise stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the sale, the director now owns 1,627 shares of the company's stock, valued at $899,275.44. This trade represents a 15.87 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 1,792 shares of company stock valued at $1,087,843. 5.70% of the stock is owned by company insiders.
Axon Enterprise Stock Performance
Shares of AXON traded up $28.12 during midday trading on Wednesday, reaching $568.11. 574,947 shares of the stock were exchanged, compared to its average volume of 852,229. The stock's 50 day simple moving average is $592.66 and its 200 day simple moving average is $539.27. The company has a market cap of $43.53 billion, a P/E ratio of 146.80, a PEG ratio of 5.17 and a beta of 1.12. Axon Enterprise, Inc. has a twelve month low of $273.52 and a twelve month high of $715.99. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently issued reports on AXON shares. The Goldman Sachs Group upped their price objective on Axon Enterprise from $500.00 to $700.00 and gave the stock a "buy" rating in a research note on Monday, January 27th. Barclays reiterated a "hold" rating on shares of Axon Enterprise in a research note on Monday, March 10th. Needham & Company LLC reiterated a "buy" rating and set a $600.00 price objective on shares of Axon Enterprise in a research note on Wednesday, February 26th. JMP Securities reiterated an "outperform" rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. Finally, TD Cowen started coverage on Axon Enterprise in a research note on Wednesday, January 8th. They set a "buy" rating and a $700.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have assigned a buy rating to the stock. According to MarketBeat.com, Axon Enterprise has a consensus rating of "Moderate Buy" and an average price target of $604.67.
View Our Latest Research Report on AXON
About Axon Enterprise
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Stories
Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
